HEALTHCARE

18 Oct 2017

Egypt to build its first pharmaceutical factory in Upper Egypt

The Governor of Minya, Essam al-Bedawi, laid the primary foundation stone for the “Brand Pharma factory” pharmaceutical industries in the industrial zone of Minya. The factory was constructed on 8000 m2 with cost that totaled LE 150 million.

"...

Continue Reading

18 Oct 2017

Shinkowa Pharmaceutical Co., Ltd., Distributor of the World's First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products ''NMN PURE 3000'' and ''NMN PURE 1500''

(AETOS Wire)-- Shinkowa Pharmaceutical Co., Ltd. (Chuo-ward, Tokyo; CEO, Megumi Tanaka) sells the first ever original supplements and cosmetics containing β-nicotinamide mononucleotide (NMN) under the 'MIRAILAB' supplement brand and"...

Continue Reading

16 Oct 2017

Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017

In the STEPSTONE open-label study, ozanimod demonstrated meaningful clinical and endoscopic improvements in patients with moderately to severely active Crohn’s disease at week 12

In the TOUCHSTONE open-label"...

Continue Reading

14 Oct 2017

AHF Donates 1 Million Sanitary Pads, Calls on Governments to Support Menstrual Health for Girls

AIDS Healthcare Foundation (AHF) is putting the spotlight on menstrual health for young women and girls through the donation of one million sanitary pads to three countries in Africa: Uganda, Nigeria and Zambia. The symbolic gesture is in honor of the 2017 International Day of the Girl Child; a United Nations recognized day that promotes the rights of girls and addresses gender inequality issues that put young women and girls at a disadvantage. It is commemorated on October 11 of every year. According to a UNESCO report, 1 in 10 girls in Sub-Saharan Africa misses school during their menstrual periods, which is about 20% of a given school year,......

Continue Reading

12 Oct 2017

Egypt raising awareness about mental illness

During the month of October, hospitals across Egypt affiliated with the General Secretariat of Mental Health, under the Ministry of Health and Population, is participating in Al-Saraya"...

Continue Reading

10 Oct 2017

Ferring Strengthens Growth Hormone Franchise Zomacton® Through Acquisition of ZomaJet™ Needle-Free Injector Device

  • Ferring enters agreement with Antares Pharma Inc. for worldwide rights to ZomaJet™ needle-free injector device
  • ZomaJet is used to deliver Ferring’s Zomacton® (somatropin), indicated to treat Growth Hormone Deficiency in children and Turner Syndrome in girls
  • ZomaJet helps increase adherence to treatment through its...

    Continue Reading

08 Oct 2017

Tour n' Cure: Egypt launches medical tourism campaign to eradicate hepatitis C

With the highest rate of hepatitis C globally, Egypt has developed an expertise in treating it. Now it is looking to share its know-how, as well as locally produced low-cost drugs, with foreigners having trouble getting treatment at home.

After"...

Continue Reading

03 Oct 2017

[Egypt] Rx Healthcare Fund announces GE healthcare as anchor investor

Rx Healthcare Fund, an Africa-focused healthcare private equity fund currently under establishment, has announced that GE Healthcare, a lglobal provider of transformational medical technologies and services, is set to become an anchor limited partner in Rx.

Following"...

Continue Reading

03 Oct 2017

Emirates Hospital Dubai: Decision to Tax Sugary Drinks Hailed

Emirates Hospital’s, a subsidiary of Emirates Healthcare Company, leading paediatrician, Dr Abeer Khayat, renounces the consumption of sugary drinks among children and youth. Sugary soft drinks and energy drinks are taxed in the UAE"...

Continue Reading

03 Oct 2017

Seattle Genetics and Takeda Announce Publication in Blood of Final Long-Term Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

-Estimated Five-Year Overall Survival Rate was 60 Percent and Five-Year Progression-Free Survival Rate was 39 Percent-

-In the 66 Percent of Patients who Achieved Complete Remission, Both Median Overall Survival"...

Continue Reading
Found articles: - Pages  
Contact US | Powered by CNPHUB.com - All Rights Reserved